Development of Nodular Lesions after Dupilumab Therapy in Erythrodermic Mycosis Fungoides with Interleukin-13 Receptor alpha2 Expression
Authors:
- Mina HashimotoMHMina Hashimoto
- Tomomitsu MiyagakiTMTomomitsu Miyagaki
- Reo KomakiRKReo Komaki
- Sora TakeuchiSTSora Takeuchi
- Takafumi KadonoTKTakafumi Kadono
Open Access
- 24 August 2022
- journal article
- editorial
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 102, adv00766
Abstract
Is missing (Short communication)Keywords
This publication has 13 references indexed in Scilit:
- Dupilumab Treatment in Two Patients with Cutaneous T-cell LymphomasActa Dermato-Venereologica, 2020
- Dupilumab and cutaneous T-cell lymphomaJournal of the American Academy of Dermatology, 2020
- IL-13 receptor α2 stimulates human glioma cell growth and metastasis through the Src/PI3K/Akt/mTOR signaling pathwayTumor Biology, 2016
- Targeting of IL-4 and IL-13 receptors for cancer therapyCytokine, 2015
- Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferationBlood, 2015
- Immunological milieu in mycosis fungoides and Sézary syndromeThe Journal of Dermatology, 2014
- IL‐13 regulates cancer invasion and metastasis through IL‐13Rα2 via ERK/AP‐1 pathway in mouse model of human ovarian cancerInternational Journal of Cancer, 2011
- Interleukin 13 Mediates Signal Transduction through Interleukin 13 Receptor α2 in Pancreatic Ductal Adenocarcinoma: Role of IL-13 Pseudomonas Exotoxin in Pancreatic Cancer TherapyClinical Cancer Research, 2010
- IL-13 signaling through the IL-13α2 receptor is involved in induction of TGF-β1 production and fibrosisNature Medicine, 2005
- AP-1 in cell proliferation and survivalOncogene, 2001